No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Inserm · Hôpital Saint-Louis · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
790
total citations
- FWCI
- 19.97
- Percentile
- 100%
- References
- 8
Citations per year
Authors
7- JMJean‐Michel MolinaCorresponding
Inserm, Hôpital Saint-Louis, Université Paris Cité
- CDConstance Delaugerre
Hôpital Saint-Louis, Université Paris Cité
- JLJ. Le Goff
Hôpital Saint-Louis, Université Paris Cité
- BMB. Mela-Lima
Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris
- DPD. Ponscarme
Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris
Topics & keywords
Topics
Keywords
- Hydroxychloroquine
- Azithromycin
- Coronavirus disease 2019 (COVID-19)
- Medicine
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- 2019-20 coronavirus outbreak
- Virology
- Intensive care medicine
No related works found for this paper.